Jae Young Seong

Lee, J. G., Ryu, J. H., Kim, S. M., Park, M. Y., Kim, S. H., Shin, Y. G., Sohn, J. W., Kim, H. H., Park, Z. Y., Seong, J. Y. & Kim, J. I., 2018 May 1, In : Biochemical Pharmacology. 151, p. 59-68 10 p.

Research output: Contribution to journal › Article

Fatty Acids

Neprilysin

Glucagon-Like Peptide 1

Therapeutics

Peptide Hydrolases

1 Citations

Evolutionary and comparative genomics to drive rational drug design, with particular focus on neuropeptide seven-transmembrane receptors

Furlong, M. & Seong, J. Y., 2017 Jan 1, In : Biomolecules and Therapeutics. 25, 1, p. 57-68 12 p.

Research output: Contribution to journal › Article

Drug Design

Genomics

Neuropeptides

Genes

Pharmaceutical Preparations

3 Citations

FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2

Park, M. Y., Kim, H. S., Lee, M., Park, B., Lee, H. Y., Cho, E. B., Seong, J. Y. & Bae, Y. S., 2017 Dec 1, In : Scientific Reports. 7, 1, 15575.

Research output: Contribution to journal › Article

Formyl Peptide Receptor

Osteoclasts

Chemokines

Osteogenesis

Brain

5 Citations

GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy

Yoo, Y., Jung, J., Lee, Y. N., Lee, Y., Cho, H., Na, E., Hong, J. Y., Kim, E., Lee, J. S., Lee, J. S., Hong, C., Park, S. Y., Wie, J., Miller, K., Shur, N., Clow, C., Ebel, R. S., DeBrosse, S. D., Henderson, L. B., Willaert, R. & 15 othersCastaldi, C., Tikhonova, I., Bilgüvar, K., Mane, S., Kim, K. J., Hwang, Y. S., Lee, S. G., So, I., Lim, B. C., Choi, H. J., Seong, J. Y., Shin, Y. B., Jung, H., Chae, J. H. & Choi, M., 2017 Sep 1, In : Annals of Neurology. 82, 3, p. 466-478 13 p.

Research output: Contribution to journal › Article

Rett Syndrome

Brain Diseases

Phenotype

Mutation

Exome